Comerica Bank Seagen Inc. Transaction History

Comerica Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 21, 2023	SELL	$191.51 - $216.16 $3.12 Million - $3.53 Million	-16,312 Reduced 89.28%	1,959 $415,000
Q2 2023 Aug 22, 2023	BUY	$187.64 - $206.25 $3.43 Million - $3.77 Million	18,271 New	18,271 $2,000
Q1 2022 Apr 27, 2022	SELL	$119.61 - $157.85 $885,592 - $1.17 Million	-7,404 Closed	0 $0
Q4 2021 Feb 18, 2022	BUY	$142.57 - $190.86 $94,809 - $126,921	665 Added 9.87%	7,404 $1.14 Million
Q3 2021 Nov 22, 2021	SELL	$142.45 - $169.82 $554,272 - $660,769	-3,891 Reduced 36.6%	6,739 $1.14 Million
Q2 2021 Aug 26, 2021	SELL	$135.08 - $161.1 $43,765 - $52,196	-324 Reduced 2.96%	10,630 $1.68 Million
Q1 2021 Apr 28, 2021	BUY	$137.51 - $190.8 $14,713 - $20,415	107 Added 0.99%	10,954 $1.52 Million
Q4 2020 Jan 28, 2021	BUY	$164.63 - $211.93 $1.79 Million - $2.3 Million	10,847 New	10,847 $1.9 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.